SAB Biotherapeutics, Inc.·4

Sep 8, 4:31 PM ET

Sullivan Eddie Joe 4

4 · SAB Biotherapeutics, Inc. · Filed Sep 8, 2022

Insider Transaction Report

Form 4
Period: 2022-09-07
Sullivan Eddie Joe
DirectorPRESIDENT
Transactions
  • Purchase

    Common Stock

    2022-09-07$0.74/sh+14,000$10,3155,230,564 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION